Target N V Biotech insider trades

Open-market stock purchases and sales by Target N V Biotech, Unknown at Molecular Templates, Inc, from SEC Form 4 filings since Nov 15, 2017.

Track record: 3% of 39 scored buys are up 5% or more since purchase, averaging -68%.

Recent trades

No open-market trades in the last 12 months.

Companies traded

  • MTEM Molecular Templates, Inc: 38 buys, 1 sale, last Nov 14, 2024
  • MGNX Macrogenics Inc: 19 buys, last Oct 2, 2023
  • RDUS Radius Health, Inc: 10 buys, last Aug 11, 2022
  • ESPR Esperion Therapeutics, Inc: 21 buys, last May 24, 2021
  • CDTX Cidara Therapeutics, Inc: 1 buy, last Nov 15, 2017

Get free alerts when Target N V Biotech files a new trade →